BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16181114)

  • 1. mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways.
    Chong ZZ; Kang J; Li F; Maiese K
    Curr Neurovasc Res; 2005 Jul; 2(3):197-211. PubMed ID: 16181114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways.
    Chong ZZ; Kang JQ; Maiese K
    Br J Pharmacol; 2003 Mar; 138(6):1107-18. PubMed ID: 12684267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system.
    Chong ZZ; Maiese K
    Histol Histopathol; 2004 Apr; 19(2):495-504. PubMed ID: 15024710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation.
    Kang JQ; Chong ZZ; Maiese K
    Mol Pharmacol; 2003 Sep; 64(3):557-69. PubMed ID: 12920191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress.
    Chong ZZ; Li F; Maiese K
    Curr Neurovasc Res; 2006 May; 3(2):107-17. PubMed ID: 16719794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential.
    Chong ZZ; Lin SH; Maiese K
    J Cereb Blood Flow Metab; 2004 Jul; 24(7):728-43. PubMed ID: 15241181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity.
    Kang JQ; Chong ZZ; Maiese K
    J Neurosci Res; 2003 Oct; 74(1):37-51. PubMed ID: 13130504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.
    Chong ZZ; Lin SH; Kang JQ; Maiese K
    J Neurosci Res; 2003 Mar; 71(5):659-69. PubMed ID: 12584724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9.
    Chong ZZ; Kang JQ; Maiese K
    Exp Cell Res; 2004 Jun; 296(2):196-207. PubMed ID: 15149850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases.
    Chong ZZ; Kang JQ; Maiese K
    Circulation; 2002 Dec; 106(23):2973-9. PubMed ID: 12460881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
    Liu F; Gong X; Zhang G; Marquis K; Reinhart P; Andree TH
    J Neurochem; 2005 Dec; 95(5):1363-72. PubMed ID: 16277616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways.
    Pi R; Li W; Lee NT; Chan HH; Pu Y; Chan LN; Sucher NJ; Chang DC; Li M; Han Y
    J Neurochem; 2004 Dec; 91(5):1219-30. PubMed ID: 15569265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis.
    Rong R; Ahn JY; Huang H; Nagata E; Kalman D; Kapp JA; Tu J; Worley PF; Snyder SH; Ye K
    Nat Neurosci; 2003 Nov; 6(11):1153-61. PubMed ID: 14528310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death.
    Vincent AM; Maiese K
    Exp Neurol; 2000 Nov; 166(1):65-82. PubMed ID: 11031084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection.
    Maiese K; Vincent A; Lin SH; Shaw T
    J Neurosci Res; 2000 Oct; 62(2):257-72. PubMed ID: 11020218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3.
    Chong ZZ; Li F; Maiese K
    Curr Neurovasc Res; 2006 Feb; 3(1):25-39. PubMed ID: 16472123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptors and dopamine receptors cooperate to enhance extracellular signal-regulated kinase phosphorylation in striatal neurons.
    Voulalas PJ; Holtzclaw L; Wolstenholme J; Russell JT; Hyman SE
    J Neurosci; 2005 Apr; 25(15):3763-73. PubMed ID: 15829628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand.
    Taylor DL; Jones F; Kubota ES; Pocock JM
    J Neurosci; 2005 Mar; 25(11):2952-64. PubMed ID: 15772355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways.
    Chong ZZ; Lin SH; Li F; Maiese K
    Curr Neurovasc Res; 2005 Oct; 2(4):271-85. PubMed ID: 16181120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
    Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.